CollPlant Biotechnologies Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 691,000 compared to USD 823,000 a year ago. Operating loss was USD 3.063 million compared to USD 1.913 million a year ago. Net loss was USD 3.038 million compared to USD 1.971 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 0.28 a year ago. For the half year, sales was USD 15.191 million compared to USD 1.432 million a year ago. Operating income was USD 6.963 million compared to operating loss of USD 3.620 million a year ago. Net income was USD 7.086 million compared to net loss of USD 3.572 million a year ago. Basic earnings per share from continuing operations was USD 0.76 compared to basic loss per share from continuing operations of USD 0.52 a year ago. Diluted earnings per share from continuing operations was USD 0.58 compared to diluted loss per share from continuing operations of USD 0.52 a year ago.